Low-frequency sonophoresis: Current status and future prospects

Advanced Drug Delivery Reviews

Volumn 60, Issue 10, 2008, Pages 1218-1223

  Ogura, Makoto ^a   Paliwal, Sumit ^a   Mitragotri, Samir ^a  

^a University of California   (United States)

Author keywords

Cavitation; Skin; Transdermal delivery; Ultrasound

Indexed keywords

CAVITATION; DRUG PRODUCTS; INSULIN; MACROMOLECULES; MECHANICAL PERMEABILITY; MOLECULAR WEIGHT; SKIN;

CYCLOSPORIN; LIDOCAINE; SONOPHORESIS; TRANSDERMAL DELIVERY;

ULTRASONICS;

CALCEIN; CYCLOSPORIN; EMLA; ERYTHROPOIETIN; GAMMA INTERFERON; INSULIN; LIDOCAINE; LOW MOLECULAR WEIGHT HEPARIN; MEPREDNISONE; PLACEBO; TETANUS TOXOID; VACCINE;

ABSENCE OF SIDE EFFECTS; ALOPECIA AREATA; CHLOASMA; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; FOLLOW UP; HUMAN; IMMUNE RESPONSE; LENTIGO; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SAFETY; SKIN NECROSIS; SKIN PERMEABILITY; SONOPHORESIS; ULTRASOUND;

ANIMALS; DRUG DELIVERY SYSTEMS; FORECASTING; HUMANS; PHARMACEUTICAL PREPARATIONS; PHONOPHORESIS; SKIN ABSORPTION; TECHNOLOGY, PHARMACEUTICAL;

EID: 44149105335     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2008.03.006     Document Type: Review

References (62)

1. Langer R. Transdermal drug delivery: past progress, current status, and future prospects. Adv. Drug. Deliv. Rev. 56 (2004) 557-558
2. Mitragotri S. Breaking the skin barrier. Adv. Drug. Deliv. Rev. 56 (2004) 555-556
3. Mitragotri S. Immunization without needles. Nat. Rev. Immunol. 5 (2005) 905-916
4. Prausnitz M.R., Mitragotri S., and Langer R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 3 (2004) 115-124
5. Cevc G. Drug delivery across the skin. Expert Opin. Investig. Drugs 6 (1997) 1887-1937
6. Cross S., and Roberts M. Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development. Curr. Drug Deliv. 1 (2004) 81-92
7. Lavon I., and Kost J. Ultrasound and transdermal drug delivery. Drug Discov. Today 9 (2004) 670-676
8. Smith E., and Maibach H. Percutaneous Penetration Enhancers (2006), CRC Press
9. Nanda A., Nanda S., and Khan Ghilzai N. Current developments using emerging transdermal technologies in physical enhancement methods. Curr. Drug Deliv. 3 (2006) 233-242
10. Elias P.M. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 80 Suppl (1983) 44s-49s
11. Lee S., McAuliffe D.J., Flotte T.J., Kollias N., and Doukas A.G. Photomechanical transcutaneous delivery of macromolecules. J Invest Dermatol 111 (1998) 925-929
12. Inoue N., Kobayashi D., Kimura M., Toyama M., Sugawara I., Itoyama S., Ogihara M., Sugibayashi K., and Morimoto Y. Fundamental investigation of a novel drug delivery system, a transdermal delivery system with jet injection. Int. J. Pharm. 137 (1996) 75-84
13. McAllister D.V., Wang P.M., Davis S.P., Park J.H., Canatella P.J., Allen M.G., and Prausnitz M.R. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc. Natl. Acad. Sci. U S A 100 (2003) 13755-13760
14. Doukas A., and Kollias N. Transdermal drug delivery with a pressure wave. Adv. Drug Deliv. Rev 56 (2004) 559-579
15. Prausnitz M.R., Lau B.S., Milano C.D., Conner S., Langer R., and Weaver J.C. A quantitative study of electroporation showing a plateau in net molecular transport. Biophys. J. 65 (1993) 414-422
16. Meyer B.R., Kreis W., Eschbach J., O'Mara V., Rosen S., and Sibalis D. Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers. Clin. Pharmacol. Ther. 44 (1988) 607-612
17. Williams A.C., and Barry B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 56 (2004) 603-618
18. Tachibana K., and Tachibana S. Transdermal delivery of insulin by ultrasonic vibration. J. Pharm. Pharmacol. 43 (1991) 270-271
19. Mitragotri S., Blankschtein D., and Langer R. Ultrasound-mediated transdermal protein delivery. Science 269 (1995) 850-853
20. Smith N.B., Lee S., Maione E., Roy R.B., McElligott S., and Shung K.K. Ultrasound-mediated transdermal transport of insulin in vitro through human skin using novel transducer designs. Ultrasound Med. Biol. 29 (2003) 311-317
21. Kost J., Mitragotri S., Gabbay R.A., Pishko M., and Langer R. Transdermal monitoring of glucose and other analytes using ultrasound. Nat. Med. 6 (2000) 347-350
22. Lee S., Nayak V., Dodds J., Pishko M., and Smith N.B. Glucose measurements with sensors and ultrasound. Ultrasound Med. Biol. 31 (2005) 971-977
23. Fellinger K., and Schmidt J. Klinik and Therapies des Chromischen Gelenkreumatismus (1954), Maudrich, Vienna 549-552
24. Mitragotri S., Blankschtein D., and Langer R. Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res. 13 (1996) 411-420
25. Tachibana K. Transdermal delivery of insulin to alloxan-diabetic rabbits by ultrasound exposure. Pharm. Res. 9 (1992) 952-954
26. Tachibana K., and Tachibana S. Use of ultrasound to enhance the local anesthetic effect of topically applied aqueous lidocaine. Anesthesiology 78 (1993) 1091-1096
27. Smith N.B. Perspectives on transdermal ultrasound mediated drug delivery. Int. J. Nanomedicine 2 (2007) 585-594
28. Mitragotri S., and Kost J. Low-frequency sonophoresis: a review. Adv. Drug Deliv. Rev. 56 (2004) 589-601
29. Merino G., Kalia Y.N., and Guy R.H. Ultrasound-enhanced transdermal transport. J. Pharm. Sci. 92 (2003) 1125-1137
30. Joshi A., and Raje J. Sonicated transdermal drug transport. J Control. Release 83 (2002) 13-22
31. Smith N.B., Lee S., and Shung K.K. Ultrasound-mediated transdermal in vivo transport of insulin with low-profile cymbal arrays. Ultrasound Med. Biol. 29 (2003) 1205-1210
32. Mitragotri S., and Kost J. Low-frequency sonophoresis: a non-invasive method for drug delivery and diagnostics. Biotech. Progress 16 (2000) 488-492
33. Tezel A., Sens A., Tuchscherer J., and Mitragotri S. Frequency dependence of sonophoresis. Pharm. Res. 18 (2001) 1694-1700
34. Tezel A., Paliwal S., Shen Z., and Mitragotri S. Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine 23 (2005) 3800-3807
35. Tezel A., Dokka S., Kelly S., Hardee G.E., and Mitragotri S. Topical delivery of anti-sense oligonucleotides using low-frequency sonophoresis. Pharm. Res. 21 (2004) 2219-2225
36. Mitragotri S., and Kost J. Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound. Pharm. Res. 18 (2001) 1151-1156
37. Mitragotri S. Innovation: healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug Discov. 4 (2005) 255-260
38. Paliwal S., and Mitragotri S. Ultrasound-induced cavitation: applications in drug and gene delivery. Expert Opin. Drug Deliv. 3 (2006) 713-726
39. Tezel A., Sens A., and Mitragotri S. Investigations of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy. J. Pharm. Sci. 91 (2002) 444-453
40. Tang H., Wang C., Blankschtein D., and Langer R. An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport. Pharm. Res. 19 (2002) 1160-1169
41. Paliwal S., Menon G.K., and Mitragotri S. Low-frequency sonophoresis: ultrastructural basis for stratum corneum permeability assessed using quantum dots. J. Invest. Dermatol. 126 (2006) 1095-1101
42. Morimoto Y., Mutoh M., Ueda H., Fang L., Hirayama K., Atobe M., and Kobayashi D. Elucidation of the transport pathway in hairless rat skin enhanced by low-frequency sonophoresis based on the solute-water transport relationship and confocal microscopy. J. Control. Release 103 (2005) 587-597
43. Cancel L., Tarbell J., and Ben-Jebria A. Fluorescein permeability and electrical resistance of human skin during low frequency ultrasound application. J. Pharm. Pharmacol. 56 (2004) 1109-1118
44. Alvarez-Roman R., Merino G., Kalia Y., Naik A., and Guy R. Skin permeability enhancement by low frequency sonophoresis: lipid extraction and transport pathways. J. Pharm. Sci. 92 (2003) 1138-1146
45. Merino G., Kalia Y.N., Delgado-Charro M.B., Potts R.O., and Guy R.H. Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis. J. Control. Release 88 (2003) 85-94
46. Kushner J.t., Blankschtein D., and Langer R. Evaluation of hydrophilic permeant transport parameters in the localized and non-localized transport regions of skin treated simultaneously with low-frequency ultrasound and sodium lauryl sulfate. J. Pharm. Sci. 97 (2008) 894-906
47. Kushner J.t., Kim D., So P.T., Blankschtein D., and Langer R.S. Dual-channel two-photon microscopy study of transdermal transport in skin treated with low-frequency ultrasound and a chemical enhancer. J. Invest. Dermatol. 127 (2007) 2832-2846
48. Kushner J.t., Blankschtein D., and Langer R. Experimental demonstration of the existence of highly permeable localized transport regions in low-frequency sonophoresis. J. Pharm. Sci. 93 (2004) 2733-2745
49. Tezel A., Sens A., Tuchscherer J., and Mitragotri S. Synergistic effect of low-frequency ultrasound and surfactants on skin permeability. J. Pharm. Sci. 91 (2002) 91-100
50. Tezel A., Sens A., and Mitragotri S. Description of transdermal transport of hydrophilic solutes during low-frequency sonophoresis based on a modified porous pathway model. J. Pharm. Sci. 92 (2003) 381-393
51. Lee S., Newnham R., and Smith N. Short ultrasound exposure times for noninvasive insulin delivery in rats using the lightweight cymbal array. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 51 (2004) 176-180
52. Lee S., Snyder B., Newnham R., and Barrie Smith N. Noninvasive ultrasonic transdermal insulin delivery in rabbits using the light-weight cymbal array. Diabetes Technol Ther. 6 (2004) 808-815
53. Luis J., Park E., Meyer Jr. R., and Smith N. Rectangular cymbal arrays for improved ultrasonic transdermal insulin delivery. J. Acoust. Soc. Am. 122 (2007) 2022
54. Park E., Werner J., and Smith N. Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer. Pharm. Res. 24 (2007) 1396-1401
55. Scharton-Kersten T., Yu J., Vassell R., O'Hagan D., Alving C.R., and Glenn G.M. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect. Immun. 68 (2000) 5306-5313
56. Santoianni P., Nino M., and Calabro G. Intradermal drug delivery by low-frequency sonophoresis (25 kHz). Dermatol. Online J. 10 (2004) 24
57. Katz N., Shapiro D., Herrmann T., Kost J., and Custer L. Rapid onset of cutaneous anesthesia with EMLA cream after pretreatment with a new ultrasound-emitting device. Anesth. Analg. 98 (2004) 371-376
58. Becker B., Helfrich S., Baker E., Lovgren K., Minugh P., and Machan J. Ultrasound with topical anesthetic rapidly decreases pain of intravenous cannulation. Acad. Emerg. Med. 12 (2005) 289
59. Boucaud A., Montharu J., Machet L., Arbeille B., Machet M., Patat F., and Vaillant L. Clinical, histologic, and electron microscopy study of skin exposed to low-frequency ultrasound. Anat. Rec. 264 (2001) 114-119
60. Tezel A., and Mitragotri S. Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. Biophys. J. 85 (2003) 3502-3512
61. Chuang H., Taylor E., and Davison T. Clinical evaluation of a continuous minimally invasive glucose flux sensor placed over ultrasonically permeated skin. Diabetes Technol. Ther. 6 (2004) 21-30
62. Kost J., Mitragotri S., Gabbay R., Pishko M., and Langer R. Transdermal monitoring of glucose and other analytes using ultrasound. Nat. Med. 6 (2000) 347-350